Shares of Valeritas Holdings Inc (NASDAQ:VLRX) dropped 3.4% during trading on Monday . The stock traded as low as $0.30 and last traded at $0.31. Approximately 753,928 shares traded hands during mid-day trading, a decline of 36% from the average daily volume of 1,171,298 shares. The stock had previously closed at $0.33.
VLRX has been the subject of several recent research reports. Zacks Investment Research raised shares of Valeritas from a “hold” rating to a “buy” rating and set a $0.50 target price for the company in a research report on Saturday, February 23rd. Oppenheimer reissued a “buy” rating on shares of Valeritas in a research report on Monday, January 14th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $2.10.
The company has a current ratio of 4.47, a quick ratio of 3.98 and a debt-to-equity ratio of 2.82. The firm has a market capitalization of $32.08 million, a PE ratio of -0.18 and a beta of 2.04.
Valeritas (NASDAQ:VLRX) last posted its quarterly earnings data on Tuesday, March 5th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.13) by ($0.07). The company had revenue of $6.89 million for the quarter, compared to analyst estimates of $6.70 million. Equities analysts predict that Valeritas Holdings Inc will post -0.56 EPS for the current year.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC raised its stake in Valeritas by 138.0% during the 4th quarter. Geode Capital Management LLC now owns 186,971 shares of the company’s stock valued at $60,000 after purchasing an additional 108,416 shares during the last quarter. Weiss Multi Strategy Advisers LLC acquired a new position in Valeritas during the 4th quarter valued at $41,000. Renaissance Technologies LLC raised its stake in Valeritas by 730.3% during the 3rd quarter. Renaissance Technologies LLC now owns 163,650 shares of the company’s stock valued at $218,000 after purchasing an additional 143,940 shares during the last quarter. Northern Trust Corp raised its stake in Valeritas by 855.4% during the 4th quarter. Northern Trust Corp now owns 185,469 shares of the company’s stock valued at $60,000 after purchasing an additional 166,057 shares during the last quarter. Finally, Millennium Management LLC acquired a new position in Valeritas during the 4th quarter valued at $165,000. 36.46% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This story was first published by Fairfield Current and is the property of of Fairfield Current. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://www.fairfieldcurrent.com/news/2019/04/17/valeritas-vlrx-shares-down-3-4.html.
Valeritas Company Profile (NASDAQ:VLRX)
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.
See Also: Diversification in Your Portfolio
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.